1) Shiffman M, Herrero R, DeSalle R, et al:The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 337:76-84, 2005
2) 笹川寿之:HPV genotypingと子宮頸癌.化療ニュース(婦人科悪性腫瘍化学療法研究機構) 15:1-5,2006
3) Sasagawa T, Basha W, Yamazaki H, et al:High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women. Cancer Epidemiol Biomarkers Prev 10:45-52, 2001
4) Munoz N, Bosch FX, de Sanjose S, et al:International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518-527, 2003
5) Matsukura T, Sugase M:Human papillomavirus genomes in squamous cell carcinomas of the uterine cervix. Virology 324:439-449, 2004
6) de RodaHusman AM, Walboomers JMM, Van Den Brule AJC, et al:The use of general primersGP5 and GP6 elongated at their3' end with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol 76:1057-1062, 1995
7) Mannos MM, Ting DK, Wright AJ, et al:The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cell 7:209-214, 1989
8) Kleter B, Van Doorn L-J, Schrauwen L, et al:Development of clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clinic Microbiol 37:2508-2517, 1999
9) Fujinaga YJ, Shimada M, Okazawa K, et al:Simultaneous detection and typing of genital human papillomavirus DNA using the polymerase chain reaction. J Gen Virol 72:1039-1044, 1991
genes of most mucosal human papillomaviurses(HPV). Virus Res 67:127-139, 2000
11) Gravitt PE, Peyton CL, Alessi TQ, et al:Improved amplification of genital human papillomavirus. J Clinic Microbiol 38:357-361, 2000